Antidepressant effect of the extracts from Fructus Akebiae

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 3, 2010, Pages 488-495

  Zhou, Dan ^a   Jin, Hong ^a   Lin, Huan Bing ^a   Yang, Xue Mei ^a   Cheng, Yu Fang ^a   Deng, Feng Jun ^a   Xu, Jiang Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; Behavior; Chronic unpredicted mild stress; Forced swim test; Fructus Akebiae; Hederagenin; Rodents; Sucrose consumption; Tail suspension test

Indexed keywords

AKEBIAE EXTRACT; ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN; ESCITALOPRAM; HEDERAGENIN; PLANT MEDICINAL PRODUCT; SUCROSE; UNCLASSIFIED DRUG;

AKEBIAE; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CHRONIC STRESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG EFFICACY; DRUG PURITY; DRUG SCREENING; DRUG SENSITIVITY; FORCED SWIMMING TEST; FRUIT; HORMONE INHIBITION; IMMOBILIZATION; MALE; MORNING DOSAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

MUS; RATTUS; RODENTIA;

EID: 71849085532     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.003     Document Type: Article

References (50)

1. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29 (2005) 525-546
2. Antai-Otong D. Antidepressant-induced insomnia: treatment options. Perspect Psychiatr Care 40 (2004) 29-33
3. Asnis G.M., Halbreich U., Ryan N.D., Rabinowicz H., Puig-Antich J., Nelson B., et al. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 12 (1987) 295-301
4. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., and Janowsky D.S. Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol Behav 57 (1995) 165-169
5. Baldwin D., Bridgman K., and Buis C. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 20 (2006) 91-96
6. Blokland A., Raaijmakers W., van der Staay F.J., and Jolles J. Differential effect of acetyl-l-carnitine on open field behavior in young and old rats. Physiol Behav 47 (1990) 783-785
7. Bourin M. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?. Fundam Clin Pharmacol 4 (1990) 49-64
8. Brenes Saenz J.C., Villagra O.R., and Fornaguera Trias J. Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats. Behav Brain Res 169 (2006) 57-65
9. Brenes J.C., and Fornaguera J. The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum. Behav Brain Res 198 (2009) 199-205
10. Bschor T., Adli M., Baethge C., Eichmann U., Ising M., Uhr M., et al. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology 27 (2002) 470-478
11. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (2005) 571-625
12. D'Aquila P.S., Peana A.T., Carboni V., and Serra G. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress. J Psychopharmacol 14 (2000) 347-352
13. D'Aquila P.S., Peana A.T., Carboni V., and Serra G. Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine. Eur J Pharmacol 399 (2000) 43-47
14. Dar A., and Khatoon S. Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacol Biochem Behav 65 (2000) 1-6
15. De Pablo J.M., Parra A., Segovia S., and Guillamon A. Learned immobility explains the behavior of rats in the forced swimming test. Physiol Behav 46 (1989) 229-237
16. Deltito J., and Beyer D. The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression. J Affect Disord 51 (1998) 345-351
17. Dias Elpo Zomkowski A., Oscar Rosa A., Lin J., Santos A.R., Calixto J.B., and Lucia Severo Rodrigues A. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023 (2004) 253-263
18. Duncan G.E., Paul I.A., Harden T.K., Mueller R.A., Stumpf W.E., and Breese G.R. Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. J Pharmacol Exp Ther 234 (1985) 402-408
19. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53 (2003) 649-659
20. Forbes N.F., Stewart C.A., Matthews K., and Reid I.C. Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav 60 (1996) 1481-1484
21. Frost P., Bornstein S., Ehrhart-Bornstein M., O'Kirwan F., Hutson C., Heber D., et al. The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat. Horm Metab Res 35 (2003) 602-606
22. Hattesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., and Winterhoff H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 15 (2008) 2-15
23. Himmerich H., Zimmermann P., Ising M., Kloiber S., Lucae S., Kunzel H.E., et al. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment. Neuropsychobiology 55 (2007) 28-35
24. Inder W.J., Prickett T.C., Mulder R.T., Donald R.A., and Joyce P.R. Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology (Berl) 156 (2001) 73-78
25. Jiang D., Gao Q.P., Shi S.P., and Tu P.F. Triterpenoid saponins from the fruits of Akebiae quinata. Chem Pharm Bull (Tokyo) 54 (2006) 595-597
26. Jozuka H., Jozuka E., Takeuchi S., and Nishikaze O. Comparison of immunological and endocrinological markers associated with major depression. J Int Med Res 31 (2003) 36-41
27. Katz R.J., Roth K.A., and Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 5 (1981) 247-251
28. Keeney A.J., and Hogg S. Behavioural consequences of repeated social defeat in the mouse: preliminary evaluation of a potential animal model of depression. Behav Pharmacol 10 (1999) 753-764
29. Khurana R.N., and Baudendistel T.E. Hypertensive crisis associated with venlafaxine. Am J Med 115 (2003) 676-677
30. Li J.M., Kong L.D., Wang Y.M., Cheng C.H., Zhang W.Y., and Tan W.Z. Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction. Life Sci 74 (2003) 55-73
31. Ossowska G., Danilczuk Z., Klenk-Majewska B., Czajkowski L., and Zebrowska-Lupina I. Antidepressants in chronic unpredictable mild stress (CUMS)-induced deficit of fighting behavior. Pol J Pharmacol 56 (2004) 305-311
32. Papp M., Moryl E., and Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296 (1996) 129-136
33. Park I.Y., Kim E.J., Park H., Fields K., Dunker A.K., and Kang C. Interaction between cardiac calsequestrin and drugs with known cardiotoxicity. Mol Pharmacol 67 (2005) 97-104
34. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
35. Sakakibara H., Ishida K., Grundmann O., Nakajima J., Seo S., Butterweck V., et al. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biol Pharm Bull 29 (2006) 1767-1770
36. Sanchez C., Gruca P., and Papp M. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behav Pharmacol 14 (2003) 465-470
37. Schechter L.E., Ring R.H., Beyer C.E., Hughes Z.A., Khawaja X., Malberg J.E., et al. Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2 (2005) 590-611
38. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
39. Swiergiel A.H., and Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 86 (2007) 651-659
40. Szafarczyk A., Ixart G., Gaillet S., Siaud P., Barbanel G., Malaval F., et al. Stress. Neurophysiologic studies. Encephale 19 Spec No 1 (1993) 137-142
41. Tesch B.J. Herbs commonly used by women: an evidence-based review. Am J Obstet Gynecol 188 (2003) S44-S55
42. Thierry B., Steru L., Simon P., and Porsolt R.D. The tail suspension test: ethical considerations. Psychopharmacology (Berl) 90 (1986) 284-285
43. Wang D., An S.C., and Zhang X. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett 433 (2008) 59-64
44. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 83 (1984) 1-16
45. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134 (1997) 319-329
46. Willner P. 1 Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005) 90-110
47. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93 (1987) 358-364
48. Zhang Z.Q., Yuan L., Yang M., Luo Z.P., and Zhao Y.M. The effect of Morinda officinalis How, a Chinese traditional medicinal plant, on the DRL 72-s schedule in rats and the forced swimming test in mice. Pharmacol Biochem Behav 72 (2002) 39-43
49. Zomkowski A.D., Santos A.R., and Rodrigues A.L. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 381 (2005) 279-283
50. Zomkowski A.D., Santos A.R., and Rodrigues A.L. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1419-1425